HBF is pleased to connect our blog readers to Christine Kukka’s monthly HBV Journal Review that she writes for the HBV Advocate. The journal presents the latest in hepatitis B research, treatment, and prevention from recent academic and medical journals. This month, the following topics are explored:
- Patients Who Clear Hepatitis B During Antiviral Treatment Do Well Long-Term
- However, the Prognosis is Poor for Most Who Stop Antiviral Treatment
- How Effective Are Antivirals in Reducing Cirrhosis and Preventing Liver Cancer?
- New Antiviral Besifovir Hampered by Carnitine Deficiency in Early Clinical Trial
- Liver Cancer Remains Major Health Threat, with Few Treatment Options
- Scientists Develop a Better Mouse for Hepatitis B and C Research
- HBV-Infected People Have a Higher Risk of Rheumatoid Arthritis
- Ear Wax May Transmit Hepatitis B
- Children with Frequent Ear Infections Do Not Respond as Well to Vaccines
- Clean-Shave Haircuts Leave Traces of Virus on the Scalp Continue reading "HBV Journal Review – November 2013"